509 related articles for article (PubMed ID: 15899874)
1. 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal.
Ghoshal K; Datta J; Majumder S; Bai S; Kutay H; Motiwala T; Jacob ST
Mol Cell Biol; 2005 Jun; 25(11):4727-41. PubMed ID: 15899874
[TBL] [Abstract][Full Text] [Related]
2. Targeting of 5-aza-2'-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme.
Patel K; Dickson J; Din S; Macleod K; Jodrell D; Ramsahoye B
Nucleic Acids Res; 2010 Jul; 38(13):4313-24. PubMed ID: 20348135
[TBL] [Abstract][Full Text] [Related]
3. HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells.
Chai G; Li L; Zhou W; Wu L; Zhao Y; Wang D; Lu S; Yu Y; Wang H; McNutt MA; Hu YG; Chen Y; Yang Y; Wu X; Otterson GA; Zhu WG
PLoS One; 2008 Jun; 3(6):e2445. PubMed ID: 18560576
[TBL] [Abstract][Full Text] [Related]
4. 5-aza-2'-deoxycytidine leads to reduced embryo implantation and reduced expression of DNA methyltransferases and essential endometrial genes.
Ding YB; Long CL; Liu XQ; Chen XM; Guo LR; Xia YY; He JL; Wang YX
PLoS One; 2012; 7(9):e45364. PubMed ID: 23028963
[TBL] [Abstract][Full Text] [Related]
5. Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells.
Vispé S; Deroide A; Davoine E; Desjobert C; Lestienne F; Fournier L; Novosad N; Bréand S; Besse J; Busato F; Tost J; De Vries L; Cussac D; Riond J; Arimondo PB
Oncotarget; 2015 Jun; 6(17):15265-82. PubMed ID: 25948775
[TBL] [Abstract][Full Text] [Related]
6. A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation.
Datta J; Ghoshal K; Denny WA; Gamage SA; Brooke DG; Phiasivongsa P; Redkar S; Jacob ST
Cancer Res; 2009 May; 69(10):4277-85. PubMed ID: 19417133
[TBL] [Abstract][Full Text] [Related]
7. 5-aza-2'-deoxycytidine-induced genome rearrangements are mediated by DNMT1.
Maslov AY; Lee M; Gundry M; Gravina S; Strogonova N; Tazearslan C; Bendebury A; Suh Y; Vijg J
Oncogene; 2012 Dec; 31(50):5172-9. PubMed ID: 22349820
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells.
Zhou Q; Agoston AT; Atadja P; Nelson WG; Davidson NE
Mol Cancer Res; 2008 May; 6(5):873-83. PubMed ID: 18505931
[TBL] [Abstract][Full Text] [Related]
9. The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells.
Yan F; Shen N; Pang J; Molina JR; Yang P; Liu S
J Biol Chem; 2015 Jul; 290(30):18480-94. PubMed ID: 26085088
[TBL] [Abstract][Full Text] [Related]
10. Novel Insights into the Molecular Mechanism of Action of DNA Hypomethylating Agents: Role of Protein Kinase C δ in Decitabine-Induced Degradation of DNA Methyltransferase 1.
Datta J; Ghoshal K; Motiwala T; Jacob ST
Genes Cancer; 2012 Jan; 3(1):71-81. PubMed ID: 22893792
[TBL] [Abstract][Full Text] [Related]
11. DNA methyltransferase 1 knockdown activates a replication stress checkpoint.
Unterberger A; Andrews SD; Weaver IC; Szyf M
Mol Cell Biol; 2006 Oct; 26(20):7575-86. PubMed ID: 17015478
[TBL] [Abstract][Full Text] [Related]
12. Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4'-thio-2'-deoxycytidine and 5-aza-4'-thio-2'-deoxycytidine.
Thottassery JV; Sambandam V; Allan PW; Maddry JA; Maxuitenko YY; Tiwari K; Hollingshead M; Parker WB
Cancer Chemother Pharmacol; 2014 Aug; 74(2):291-302. PubMed ID: 24908436
[TBL] [Abstract][Full Text] [Related]
13. 5-aza-2'-deoxycytidine induces alterations in murine spermatogenesis and pregnancy outcome.
Kelly TL; Li E; Trasler JM
J Androl; 2003; 24(6):822-30. PubMed ID: 14581508
[TBL] [Abstract][Full Text] [Related]
14. 5-Aza-2'-deoxycytidine, a DNA methylation inhibitor, induces cytotoxicity, cell cycle dynamics and alters expression of DNA methyltransferase 1 and 3A in mouse hippocampus-derived neuronal HT22 cells.
Yang J; Tian X; Yang J; Cui J; Jiang S; Shi R; Liu Y; Liu X; Xu W; Xie W; Jia X; Bade R; Zhang T; Zhang M; Gong K; Yan S; Yang Z; Shao G
J Toxicol Environ Health A; 2017; 80(22):1222-1229. PubMed ID: 28880816
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.
Palii SS; Van Emburgh BO; Sankpal UT; Brown KD; Robertson KD
Mol Cell Biol; 2008 Jan; 28(2):752-71. PubMed ID: 17991895
[TBL] [Abstract][Full Text] [Related]
16. AID downregulation is a novel function of the DNMT inhibitor 5-aza-deoxycytidine.
Tsai CT; Yang PM; Chern TR; Chuang SH; Lin JH; Klemm L; Müschen M; Chen CC
Oncotarget; 2014 Jan; 5(1):211-23. PubMed ID: 24457556
[TBL] [Abstract][Full Text] [Related]
17. High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors.
Beyrouthy MJ; Garner KM; Hever MP; Freemantle SJ; Eastman A; Dmitrovsky E; Spinella MJ
Cancer Res; 2009 Dec; 69(24):9360-6. PubMed ID: 19951990
[TBL] [Abstract][Full Text] [Related]
18. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
Lin HY; Kuo YC; Weng YI; Lai IL; Huang TH; Lin SP; Niu DM; Chen CS
Prostate; 2012 Dec; 72(16):1767-78. PubMed ID: 22539223
[TBL] [Abstract][Full Text] [Related]
19. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements.
Liang G; Chan MF; Tomigahara Y; Tsai YC; Gonzales FA; Li E; Laird PW; Jones PA
Mol Cell Biol; 2002 Jan; 22(2):480-91. PubMed ID: 11756544
[TBL] [Abstract][Full Text] [Related]
20. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine.
Karpf AR; Moore BC; Ririe TO; Jones DA
Mol Pharmacol; 2001 Apr; 59(4):751-7. PubMed ID: 11259619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
